1-158547937-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001005189.2(OR6Y1):c.169G>T(p.Asp57Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,560 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001005189.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR6Y1 | NM_001005189.2 | c.169G>T | p.Asp57Tyr | missense_variant | 2/2 | ENST00000641622.1 | NP_001005189.1 | |
OR6Y1 | NM_001386050.1 | c.169G>T | p.Asp57Tyr | missense_variant | 2/2 | NP_001372979.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR6Y1 | ENST00000641622.1 | c.169G>T | p.Asp57Tyr | missense_variant | 2/2 | NM_001005189.2 | ENSP00000492894 | P1 | ||
OR6Y1 | ENST00000641282.1 | c.169G>T | p.Asp57Tyr | missense_variant | 2/2 | ENSP00000493253 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000798 AC: 2AN: 250772Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135516
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461560Hom.: 0 Cov.: 33 AF XY: 0.00000275 AC XY: 2AN XY: 727096
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 04, 2022 | The c.169G>T (p.D57Y) alteration is located in exon 1 (coding exon 1) of the OR6Y1 gene. This alteration results from a G to T substitution at nucleotide position 169, causing the aspartic acid (D) at amino acid position 57 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at